NG Bio
Richard Kaschula is currently the Principal at NG Bio, a venture investor focused on early-stage therapeutic opportunities in autoimmune and chronic inflammatory diseases. Prior to their current role, Richard served as a Venture Builder at LifeArc and as a Technology Transfer Fellow at The Francis Crick Institute. Richard holds a PhD in Biology/Biological Sciences, an MFin in Finance, an MSc in Cell and Developmental Biology, and a BSc in Biological and Medicinal Chemistry.
This person is not in any teams
NG Bio
At NG Bio we build therapeutic ventures that can change outcomes for patients with autoimmune and chronic inflammatory diseases. Our team of scientists, drug developers and entrepreneurs work with academic and scientific founders to give their technologies the highest chance to getting to the patients who need them most.